Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Current Leases (2019 - 2025)

Avanos Medical (AVNS) has disclosed Current Leases for 7 consecutive years, with $8.2 million as the latest value for Q4 2025.

  • Quarterly Current Leases fell 24.77% to $8.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.2 million through Dec 2025, down 24.77% year-over-year, with the annual reading at $8.2 million for FY2025, 24.77% down from the prior year.
  • Current Leases hit $8.2 million in Q4 2025 for Avanos Medical, down from $9.5 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $15.1 million in Q1 2021 to a low of $8.2 million in Q4 2025.
  • Historically, Current Leases has averaged $12.6 million across 5 years, with a median of $13.1 million in 2022.
  • Biggest five-year swings in Current Leases: rose 7.87% in 2024 and later plummeted 30.66% in 2025.
  • Year by year, Current Leases stood at $14.7 million in 2021, then fell by 18.37% to $12.0 million in 2022, then increased by 6.67% to $12.8 million in 2023, then decreased by 14.84% to $10.9 million in 2024, then dropped by 24.77% to $8.2 million in 2025.
  • Business Quant data shows Current Leases for AVNS at $8.2 million in Q4 2025, $9.5 million in Q3 2025, and $10.4 million in Q2 2025.